PFM
Peak Financial Management Portfolio holdings
AUM
$352M
This Quarter Return
-2.18%
1 Year Return
+11.68%
3 Year Return
+35.93%
5 Year Return
+53.92%
10 Year Return
–
AUM
$334M
AUM Growth
+$334M
(-2%)
Cap. Flow
+$29.4M
Cap. Flow
% of AUM
8.8%
Top 10 Holdings %
Top 10 Hldgs %
51.56%
Holding
105
New
7
Increased
46
Reduced
32
Closed
9
Top Buys
| 1 |
Schwab US Mid-Cap ETF
SCHM
|
$6.79M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
$6.66M |
| 3 |
Schwab US TIPS ETF
SCHP
|
$6.19M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
$3.42M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
$3.12M |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$718K |
| 2 |
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
|
$387K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$316K |
| 4 |
Novo Nordisk
NVO
|
$283K |
| 5 |
Advanced Micro Devices
AMD
|
$253K |
Sector Composition
| 1 | Technology | 5.19% |
| 2 | Communication Services | 0.77% |
| 3 | Consumer Discretionary | 0.66% |
| 4 | Industrials | 0.47% |
| 5 | Consumer Staples | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Johnson & Johnson
JNJ
$427B
| – | – |
-1,425
| Closed | -$231K |
|
102
Merck
MRK
$210B
| – | – |
-2,203
| Closed | -$250K |
|
|
103
Novo Nordisk
NVO
$251B
| – | – |
-2,374
| Closed | -$283K |
|
|
104
Vertex Pharmaceuticals
VRTX
$100B
| – | – |
-680
| Closed | -$316K |
|
105
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38B
| – | – |
-4,380
| Closed | -$224K |
|